Video

Dr. VanderWalde on Future Research in Rectal Cancer

Noam VanderWalde, MD, MS, discusses ​where future research ​efforts should focus in rectal cancer. 

Noam VanderWalde, MD, MS, associate professor of radiation oncology, West Cancer Center and Research Institute, discusses ​where future research ​efforts should focus in rectal cancer. 

Treatment personalization in terms of medical management, patient preference, and health-related quality of life, needs to be further evaluated, says VanderWalde. 

Moreover, factors that influence decision making should be assessed, VanderWalde explains.

Typically, surgical eligibility based on results from physical exams and and MRI; however, circulating tumor DNA may provide better insight ​on whether a patient should undergo surgery, VanderWalde concludes.

Related Videos
Alan Tan, MD, genitourinary oncology and melanoma specialist, Vanderbilt-Ingram Cancer Center; associate professor, medicine, Division of Hematology Oncology, Vanderbilt University Medical Center
Zosia Piotrowska, MD, MHS, instructor, Harvard Medical School; medical oncologist, Massachusetts General Hospital
Bartosz Chmielowski, MD
Raza Hoda, MD, FASCP
Armin Ghobadi, MD, professor, medicine, Oncology, Section of Bone Marrow Transplant; clinical director, Center for Gene and Cellular Immunotherapy, Siteman Cancer Center, Washington University
Timothy S. Fenske, MD, MS
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Roxana S. Dronca, MD, discusses the FDA’s approval of subcutaneous nivolumab across solid tumor indications.
Craig Eckfeldt, MD
Whitney Goldsberry, MD